Karlsson J, Wahlberg F, Kaijser C, Sannerstedt R
Int J Sports Med. 1985 Jun;6(3):169-73. doi: 10.1055/s-2008-1025833.
Thirty-four untreated patients with essential hypertension WHO I-II, 17 patients under treatment with beta-blockade, and 32 healthy controls with a wide range of exercise capacity were studied at loadless pedaling (W0) and at the work load eliciting a blood lactate concentration corresponding to 4 mmol X l-1 (onset of blood lactate accumulation or OBLA). At W0 the treated patients had approximately the same systolic blood pressure (SBP) as the healthy controls, while the untreated patients had a higher SBP than the controls. At WOBLA the SBP was higher in the untreated patients than in both the treated patients and the healthy controls. On an individual basis it was found in the healthy controls and the untreated patients that the SBP at WOBLA showed a slight and insignificant increase versus SBP at W0, whereas the difference in SBP between WOBLA and W0 ("exercise SBP increase") demonstrated an inverse relationship (P less than 0.001-0,01) versus W0. It was suggested that for both healthy controls and untreated patients the exercise SBP depended on a "basal" level as depicted by W0 and a further SBP increase due to the exercise load. The difference between the two groups was that the patients with untreated hypertension displayed their relationships at higher pressure levels indicating the presence of a hyperkinetic drive. The treated patients appeared to have a lower increase in SBP between W0 and WOBLA than any other group, suggesting an unfavorable effect of the beta-blockade.
对34例未经治疗的WHO I-II级原发性高血压患者、17例接受β受体阻滞剂治疗的患者以及32例具有广泛运动能力的健康对照者,在无负荷蹬车(W0)时以及在使血乳酸浓度达到4 mmol/L(血乳酸堆积起始点或OBLA)的工作负荷下进行了研究。在W0时,接受治疗的患者收缩压(SBP)与健康对照者大致相同,而未经治疗的患者SBP高于对照者。在WOBLA时,未经治疗的患者SBP高于接受治疗的患者和健康对照者。就个体而言,在健康对照者和未经治疗的患者中发现,WOBLA时的SBP与W0时相比有轻微且无统计学意义的升高,而WOBLA和W0之间SBP的差异(“运动性SBP升高”)与W0呈负相关(P<0.001 - 0.01)。提示对于健康对照者和未经治疗的患者,运动性SBP取决于W0所描绘的“基础”水平以及运动负荷导致的SBP进一步升高。两组之间的差异在于,未经治疗的高血压患者在更高的压力水平上呈现出这些关系,表明存在高动力驱动。接受治疗的患者在W0和WOBLA之间SBP的升高似乎低于其他任何组,提示β受体阻滞剂有不良影响。